{"organizations": [], "uuid": "81e8c8db3ba7888bfe553ac6ff39bf5df7f369e5", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/6", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/02/13/globe-newswire-annual-general-meeting-in-alk-abella-as-on-12-march-2018.html", "country": "US", "domain_rank": 767, "title": "Annual General Meeting in ALK-Abelló A/S on 12 March 2018", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.435, "site_type": "news", "published": "2018-02-13T15:55:00.000+02:00", "replies_count": 0, "uuid": "81e8c8db3ba7888bfe553ac6ff39bf5df7f369e5"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/02/13/globe-newswire-annual-general-meeting-in-alk-abella-as-on-12-march-2018.html", "ord_in_thread": 0, "title": "Annual General Meeting in ALK-Abelló A/S on 12 March 2018", "locations": [], "entities": {"persons": [{"name": "jeppe ilkjær", "sentiment": "none"}], "locations": [{"name": "dc", "sentiment": "none"}, {"name": "hørsholm", "sentiment": "none"}, {"name": "denmark", "sentiment": "none"}], "organizations": [{"name": "alk", "sentiment": "none"}, {"name": "alk-abelló a/s", "sentiment": "none"}, {"name": "bøge allé", "sentiment": "none"}, {"name": "agm", "sentiment": "none"}, {"name": "nasdaq copenhagen", "sentiment": "none"}, {"name": "board of directors", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ): The annual general meeting of ALK-Abelló A/S will take place on Monday 12 March 2018 at 16:00 (CET) at ALK-Abelló A/S, 1 Bøge Allé, 2970 Hørsholm, Denmark. The agenda of the meeting including the complete proposals from the Board of Directors to the AGM is attached.\nALK-Abelló A/S\nFor further information please contact:\nInvestor Relations : Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525\nMedia: Jeppe Ilkjær, tel. +45 7877 4532, mobile +45 3050 2014\nAbout ALK\nALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctors. Headquartered in Hørsholm, Denmark, ALK employs around 2,300 people worldwide and is listed on Nasdaq Copenhagen. Find more information at www.alk.net .\nAttachments:\nhttp://www.globenewswire.com/NewsRoom/AttachmentNg/fdfb0e5d-f82b-4a25-b5ed-1bff3cec6fb5\nSource: ALK-Abello", "external_links": ["http://www.globenewswire.com/NewsRoom/AttachmentNg/fdfb0e5d-f82b-4a25-b5ed-1bff3cec6fb5", "https://www.globenewswire.com/Tracker?data=-Dt2RcoRPXq6Z5m64t58Hypeot-1iXlgfgOLIinJJWI7U6htrw62vS_cFPvl1DKT1CAVSTb5ZBoLFz8p9Nl4q5ZGHCk9g8EGyZO6ZidawVqrvuNJ2xXjNHJODlY8y6_jgtgkTtpyzrcJ-AEgAZThRfs3DR-ED9OxNQC9IzLkvZVKpzoh8MxripQpt83G1wHiT2az0ZOWjlQxbzTronHVdwO3M4k2Gv9lB4TacSkd2jIJJZube-ZiOSpTj1E9uceHcojB4hjpXfgbEPg6zWn7iw==", "https://www.globenewswire.com/Tracker?data=fIXG6J1o2qqkR1VH10jd1PABIwyStW0be4Ckl0T0qBFHm3LU7SyObv17Px9G3v7BCPnWQZ8V9GgW7narUafCgA==", "https://www.globenewswire.com/Tracker?data=MGhpEARQSjOUjTCL6ZXfMeFkmw4qQSxY-ZdRyQhQYBVSlQ9lVR12UqCqSkMUvubi"], "published": "2018-02-13T15:55:00.000+02:00", "crawled": "2018-02-13T17:23:12.000+02:00", "highlightTitle": ""}